218 related articles for article (PubMed ID: 29150944)
1. Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer.
Moradi-Marjaneh R; Hassanian SM; Fiuji H; Soleimanpour S; Ferns GA; Avan A; Khazaei M
J Cell Physiol; 2018 Aug; 233(8):5613-5622. PubMed ID: 29150944
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor signalling and their therapeutic targeting in colorectal cancer.
Moossavi S; Rezaei N
Int Immunopharmacol; 2013 Jun; 16(2):199-209. PubMed ID: 23602501
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor agonists in cancer therapy.
Adams S
Immunotherapy; 2009 Nov; 1(6):949-64. PubMed ID: 20563267
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptors: cost or benefit for cancer?
Matijevic T; Pavelic J
Curr Pharm Des; 2010; 16(9):1081-90. PubMed ID: 20030618
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors: The role in bladder cancer development, progression and immunotherapy.
Ohadian Moghadam S; Nowroozi MR
Scand J Immunol; 2019 Dec; 90(6):e12818. PubMed ID: 31448424
[TBL] [Abstract][Full Text] [Related]
7. Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility.
Sameer AS; Nissar S
Biomed Res Int; 2021; 2021():1157023. PubMed ID: 34552981
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the microbiota and their secretory products to inflammation and colorectal cancer pathogenesis: the role of toll-like receptors.
Sheikh A; Taube J; Greathouse KL
Carcinogenesis; 2021 Oct; 42(9):1133-1142. PubMed ID: 34218275
[TBL] [Abstract][Full Text] [Related]
9. [Study on Toll-like receptors expression and cytokine production induced by bacillus Calmette-Guerin in human bladder cancer cell].
Li X; Gong ZY; Li H; Wei Q; Shi M; Yang YR
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):177-81. PubMed ID: 15062066
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors: Triggers of regulated cell death and promising targets for cancer therapy.
Yang Y; Feng R; Wang YZ; Sun HW; Zou QM; Li HB
Immunol Lett; 2020 Jul; 223():1-9. PubMed ID: 32311408
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of toll-like receptors in gastrointestinal inflammation.
Ishihara S; Rumi MA; Ortega-Cava CF; Kazumori H; Kadowaki Y; Ishimura N; Kinoshita Y
Curr Pharm Des; 2006; 12(32):4215-28. PubMed ID: 17100624
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
Fukata M; Vamadevan AS; Abreu MT
Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
[TBL] [Abstract][Full Text] [Related]
13. The application of Toll like receptors for cancer therapy.
So EY; Ouchi T
Int J Biol Sci; 2010 Nov; 6(7):675-81. PubMed ID: 21060729
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of TLRs and IL-6 as a marker in human colorectal cancer.
Lu CC; Kuo HC; Wang FS; Jou MH; Lee KC; Chuang JH
Int J Mol Sci; 2014 Dec; 16(1):159-77. PubMed ID: 25547486
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in the development of Toll-like receptor (TLR) antagonists.
Patra MC; Choi S
Expert Opin Ther Pat; 2016 Jun; 26(6):719-30. PubMed ID: 27136061
[TBL] [Abstract][Full Text] [Related]
16. Eicosanoid pathway in colorectal cancer: Recent updates.
Tuncer S; Banerjee S
World J Gastroenterol; 2015 Nov; 21(41):11748-66. PubMed ID: 26557000
[TBL] [Abstract][Full Text] [Related]
17. Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics.
Gomariz RP; Gutiérrez-Cañas I; Arranz A; Carrión M; Juarranz Y; Leceta J; Martínez C
Curr Pharm Des; 2010; 16(9):1063-80. PubMed ID: 20030612
[TBL] [Abstract][Full Text] [Related]
18. The Therapeutic Potential of Targeting the Toll-like Receptor Pathway in Breast Cancer.
Toroghian Y; Khayyami R; Hassanian SM; Nassiri M; Ferns GA; Khazaei M; Avan A
Curr Pharm Des; 2022; 28(27):2203-2210. PubMed ID: 35909287
[TBL] [Abstract][Full Text] [Related]
19. Role of toll-like receptors in multiple myeloma and recent advances.
Thakur KK; Bolshette NB; Trandafir C; Jamdade VS; Istrate A; Gogoi R; Cucuianu A
Exp Hematol; 2015 Mar; 43(3):158-67. PubMed ID: 25462020
[TBL] [Abstract][Full Text] [Related]
20. Small-Molecule Modulators of Toll-like Receptors.
Wang Y; Zhang S; Li H; Wang H; Zhang T; Hutchinson MR; Yin H; Wang X
Acc Chem Res; 2020 May; 53(5):1046-1055. PubMed ID: 32233400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
